CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...
Phase 2
•Dallas, Texas, United States and 6 other locations
multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...
Phase 2
•Dallas, Texas, United States and 6 other locations
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
•Dallas, Texas, United States and 217 other locations
tissue derived mesenchymal stem cells (AdMSC), in patients with COVID-19 pneumonia. After each subject completes 12-Weeks visit (Vi...
Phase 1, Phase 2
•Dallas, Texas, United States and 1 other location
Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.
Plano, Texas, United States and 6 other locations
of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...
Phase 1, Phase 2
•Dallas, Texas, United States and 11 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
•Dallas, Texas, United States and 66 other locations
(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...
Phase 2
•Euless, Texas, United States and 144 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
•Dallas, Texas, United States and 214 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
•Dallas, Texas, United States of America and 114 other locations
Clinical trials
Research sites
Resources
Legal